251 - 275 of 918
Number of results to display per page
TitleCreatorDate
251 Parenchymal Anaplastic Astrocytoma Presenting With Visual Symptoms Due to Bilateral Optic Nerve Sheath InvolvementBui, Kelly M; Farooq, Asim V; Moss, Heather E; Lin, Amy Y; Valyi-Nagy, Tibor; Villano, J Lee
252 Treatment Response in Pediatric Patients With Pseudotumor Cerebri SyndromeEliel Tovia, MD, Shimon Reif, MD, Asaf Oren, MD, Alexis Mitelpunkt, MD, Aviva Fattal-Valevski, MD, MHA2017-12
253 Prognosticators of Visual Acuity After Indirect Traumatic Optic NeuropathyAlex J. Wright, Joanna H. Queen, Emilio P. Supsupin, Alice Z. Chuang, John J. Chen, Rod Foroozan, Ore-Ofe O. Adesina2022-06
254 Visual Pathway Axonal Loss in Benign Multiple SclerosisGaletta, Kristin M; Graves, Jennifer; Talman, Lauren S; Lile, Deacon J; Frohman, Elliot M; Calabresi, Peter A; Galetta, Steven L; Balcer, Laura J
255 Involvement of Ocular Muscles in Patients With Myasthenia Gravis With Nonocular OnsetLei L, Fan Z, Su S, Xu M, Chen H, Zhu W, Luan Q, Da Y.2022-03
256 Simultaneous, Multiple Cranial Neuropathies in Diabetes MellitusEshbaugh, CG; Siatkowski, RM; Smith, JL; Kline, LB
257 Intravitreal Bevacizumab in the Treatment of Peripapillary Choroidal Neovascular Membrane Secondary to Idiopathic Intracranial HypertensionIn-Jung Lee, BSc, BAppSc, MBBS, Luke J. Maccheron, BMedSc, MBBS, FRANZCO, Anthony S. Kwan, MBChB, MD, FRCOphth, FRANZCO2013-06
258 Intravitreal Bevacizumab in the Treatment of Peripapillary Choroidal Neovascular Membrane Secondary to Idiopathic Intracranial HypertensionLee, In-Jung; Maccheron, Luke J; Kwan, Anthony S
259 Comments on Disorders of the Fourth Cranial Nerve: ResponseJoseph L. Demer, MD; Lanning B. Kline, MD; Michael S. Vaphiades, MD; Mehdi Tavakoli, MD2021-12
260 Late-Onset Lebers Hereditary Optic NeuropathyAjax, ET; Kardon, R
261 Neuro-Ophthalmology in MalawiSchulze Schwering, Markus; Kayange, Petros; Wilhelm, Helmut; Digre, Kathleen B
262 Pediatric Optic Nerve Sheath MeningiomaBeccari, Serena; Cima, Luca; Posenato, Ilaria; Sala, Francesco; Ghimenton, Claudio; Brunelli, Matteo; Eccher, Albino
263 Recurrent Bilateral Myelin Oligodendrocyte Glycoprotein Antibody Optic Neuritis in a Leber Hereditary Optic Neuropathy CarrierSubahari Raviskanthan, Nayomi Perera, Anthony Fok2020-06
264 Table of Contents
265 Should Visual Restoration Therapy be Used in Patients With Visual Field Loss?Neil R. Miller; Prem S. Subramanian
266 Vestibular Migraine: How to Sort it Out and What to Do About itShin C. Beh2019-06
267 Association Between Phosphodiesterase-5 Inhibitors and Nonarteritic Anterior Ischemic Optic NeuropathyNawaaz A Nathoo; Mahyar Etminan; Frederick S Mikelberg
268 Anemia and Idiopathic Intracranial Hypertension: A Systematic Review and Meta-analysisCaberry W. Yu, MD, Ethan Waisberg, MB BcH, Jason M. Kwok, MD, Jonathan A. Micieli, MD2022-03
269 Neuro-Ophthalmological Complications of the COVID-19 Vaccines: A Systematic ReviewItay Lotan, Melissa Lydston, Michael Levy2022-06
270 The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell ArteritisArjun V Jogimahanti, Ashwini T Kini, Lauren E Irwin, Andrew G Lee2021-09
271 Literature Commentary2020-12
272 Optic Neuritis After SARS-CoV-2 VaccinationAsaf Shemer, MD; Assaf Greenbaum, MD; Amit Toledano, MD; Roy Biron, MD; Biana Dubinsky-Pertzov, MD, MPH; Lior Or, MD2023-03
273 Laser Pointer Visual Field ScreeningLee, MS; Balcer, LJ; Volpe, NJ; Liu, GT; Ying, GS; Galetta, SL1994-06
274 Multiple Intracranial Meningiomas Causing Papilledema and Visual Loss in a Patient with Nevoid Basal Cell Carcinoma SyndromePribila, JT; Ronan, SM; Trobe, JD
275 Antibody Development in Patients Treated Long-Term With OnabotulinumtoxinA for Benign Essential Blepharospasm and Hemifacial SpasmCraig N. Czyz, DO, John A. Burns, MD, Reece E. Bergstrom, DO2021-12
251 - 275 of 918